Skip to main content

Peer Review reports

From: Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial

Original Submission
17 Jan 2022 Submitted Original manuscript
26 Feb 2022 Reviewed Reviewer Report - Yaseen Arabi
7 Mar 2022 Reviewed Reviewer Report - St. Anthony Amofah
5 Apr 2022 Author responded Author comments - Moataz Maher Emara
Resubmission - Version 2
5 Apr 2022 Submitted Manuscript version 2
25 Apr 2022 Reviewed Reviewer Report - St. Anthony Amofah
28 Apr 2022 Reviewed Reviewer Report - Yaseen Arabi
11 May 2022 Reviewed Reviewer Report - Kirsty Loudon
23 May 2022 Author responded Author comments - Moataz Maher Emara
Resubmission - Version 3
23 May 2022 Submitted Manuscript version 3
1 Jun 2022 Reviewed Reviewer Report - Kirsty Loudon
28 Jul 2022 Reviewed Reviewer Report - Patrick Musonda
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
2 Aug 2022 Editorially accepted
8 Aug 2022 Article published 10.1186/s13063-022-06619-9

You can find further information about peer review here.

Back to article page